A detailed history of Alphabet Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Alphabet Inc. holds 23,205 shares of EXAS stock, worth $1.28 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
23,205
Previous 23,205 -0.0%
Holding current value
$1.28 Million
Previous $980,000 61.22%
% of portfolio
0.11%
Previous 0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 14, 2022

BUY
$90.24 - $124.05 $2.09 Million - $2.88 Million
23,205 New
23,205 $2.22 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.76B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Alphabet Inc. Portfolio

Follow Alphabet Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alphabet Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alphabet Inc. with notifications on news.